Aktien Sensor

Roche Holding AG’s stock price has experienced significant fluctuations in recent years, but a decade-long investment would have yielded substantial returns, and the approval of its new treatment Columvi in Canada is expected to boost the company’s …

Lonza Group AG has demonstrated resilience in the face of market volatility, driven by its strong fundamentals and strategic partnerships in the life sciences sector.

Bristol-Myers Squibb’s stock price has declined by 25% over the past decade, but the biopharmaceutical industry is expected to grow due to increasing demand for innovative treatments, including those for uveal melanoma and cancer.

Terumo Corp’s stable stock price and moderate valuation demonstrate the company’s resilience in the face of market fluctuations, making it a promising player in the evolving healthcare industry.

Align Technology Inc. is facing a patent infringement claim from Angelalign Technology Inc., which may impact the company’s stock performance and market value.

Intuitive Surgical Inc.’s stock price has seen a moderate increase due to the successful launch of its new Da Vinci 5 surgical system, despite the overall market experiencing a decline.

Jiangsu Hengrui Pharmaceuticals Co Ltd reported a 12% increase in quarterly revenue to a record 9.16 billion HKD, driven by its focus on innovative drug sales and international expansion.

Siemens Healthineers AG is well-positioned for growth in the medical technology market due to increasing demand for equipment maintenance and diagnostic imaging solutions.

AbbVie has made a $2.1 billion acquisition of Capstan Therapeutics, positioning itself to lead in cancer research and treatment with cutting-edge tools and technologies.

Fresenius SE & Co KGaA’s stock price has more than doubled in the past year, driven by growing demand for healthcare services, but its future prospects are uncertain due to ongoing German healthcare reform debates.